First Online: 25 July 2019
Change Date: 5 November 2019
Change Type: Correction
Change Details: .
Ethics approval and consent to participate
: The study protocol was approved by the Mount Sinai Institutional Review Board (IRB), and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP). Informed consent was obtained from all patients.
: Not applicable.
: KLA, EES, SDL, and RC are employees of Sema4, a Mount Sinai venture. OF, AR, EES, and JLMB are employees of Clinical Gene Networks AB. The rest of authors declare they have no competing interest.